This inventor holds 41 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Magnetic Nanoparticles. Top assignees: Advanced Magnetics, Inc., The General Hospital Corporation, Baxter Travenol Laboratories, Inc.. Active years: 1981-2023.
Location History:
- Arlington, MA (US) (1981 - 2013)
- Reading, MA (US) (2010 - 2023)
Company Filing History:
28 out of 31 
11 out of 3,070 
1 out of 809 
Years Active: 1981-2023
Areas of Expertise:
Title: Lee Josephson: Innovator in Nucleic Acid Detection Technologies
Introduction
Lee Josephson, located in Arlington, MA, is a distinguished inventor with a remarkable portfolio that includes 41 patents. His contributions to the fields of nanotechnology and molecular diagnostics are notable, particularly through his innovative work with nucleic acid binding fluorescent nanoprobes.
Latest Patents
Josephson's latest patents showcase significant advancements in the area of diagnostic technologies. One of his prominent inventions, titled "Theranostic nucleic acid binding fluorescent nanoprobes and uses thereof," introduces a novel approach to detecting nucleic acids by utilizing nanoprobes equipped with multiple fluorochromes connected to a polymer. This technology enhances the sensitivity and accuracy of nucleic acid detection.
Another significant patent is the "Heat-induced radiochemical labeling of an iron oxide nanoparticle," where he details a method for synthesizing radiolabeled nanoparticles. This innovative technique includes the heating of iron oxide nanoparticles in the presence of radioactive metal ions, ultimately facilitating the formation of radiolabeled particles. The method also incorporates the use of a quenching agent to efficiently remove non-bound radioactive ions, ensuring the purity of the final product.
Career Highlights
Lee Josephson’s career has been marked by significant achievements in various organizations. He has worked with Advanced Magnetics, Inc. and The General Hospital Corporation, where he contributed to groundbreaking research in molecular imaging and diagnostics. His innovation-driven approach has paved the way for advanced applications in medicine and healthcare.
Collaborations
Throughout his career, Josephson has collaborated with esteemed colleagues such as Ernest V. Groman and Jerome M. Lewis. These partnerships have facilitated the exchange of ideas and technologies, leading to the development of innovative solutions in the field of biomedical research.
Conclusion
In summary, Lee Josephson remains a prominent figure in the realm of technological innovation, particularly in the development of advanced nanoprobes and radiolabeled nanoparticles. His extensive patent portfolio and collaborations with key professionals continue to influence the landscape of molecular diagnostics and therapeutic applications.